![Steven Vroegop](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Vroegop
Corporate Officer/Principal presso Michigan High Throughput Screening Center
Posizioni attive di Steven Vroegop
Società | Posizione | Inizio | Fine |
---|---|---|---|
Michigan High Throughput Screening Center
![]() Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties. | Corporate Officer/Principal | - | - |
Direttore Tecnico/Scientifico/R&S | 30/04/2010 | 30/04/2010 |
Storia della carriera di Steven Vroegop
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Michigan High Throughput Screening Center
![]() Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties. | Commercial Services |
- Borsa valori
- Insiders
- Steven Vroegop
- Esperienza